Ultrasound Guided Foam Sclerotherapy for the Management of Recurrent Varicose Veins

  • Christopher Richard Lattimer
  • Mustapha Azzam

Case Report

A 67-year old man presented with left leg discomfort and gaiter pruritus which interfered with his retirement lifestyle. His symptoms were worse after prolonged standing and towards the end of the day. Below knee graduated elastic compression (GCS) stockings provided him with some relief. He suffered with poliomyelitis at 12 years old which caused leg muscle wasting. Seven years previously he had his left great saphenous vein (GSV) stripped to the knee with multiple phlebectomies. This alleviated similar symptoms but resulted in persistent ankle edema.

Question 1

Which of the following are recurrent varicose veins?
  1. A.

    Varicose veins draining into a neovascularisation following crossectomy.

  2. B.

    Residual veins after incomplete phlebectomies.

  3. C.

    Remaining varicosities after endovenous laser ablation.

  4. D.

    Remaining varicosities after foam sclerotherapy.

  5. E.

    Primary short saphenous varicosities after a GSV strip.


The patient had already undergone surgical treatment for...


  1. 1.
    Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther. 2006;13:357–64.CrossRefPubMedGoogle Scholar
  2. 2.
    Perrin MR, Guex JJ, Ruckley CV, et al. Recurrent varices after surgery (REVAS), a consensus document. Cardiovasc Surg. 2000;8(4):233–45.CrossRefPubMedGoogle Scholar
  3. 3.
    Perrin MR. Presence of varicies after operative treatment; a review. Phlebolymphology. 2014;21(3):158–68.Google Scholar
  4. 4.
    Mendoza E, Lattimer CR, Morrison N. Duplex ultrasound of superficial leg veins. London: Springer-Verlag; 2014. ISBN: 978-3642407307CrossRefGoogle Scholar
  5. 5.
    Fischer R, Linde N, Duff C, Jeanneret C, Chandler JG, Seeber P. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg. 2001;34:236–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence: late results of a randomized controlled trial of stripping the long saphenous vein. J Vasc Surg. 2004;40:634–9.CrossRefPubMedGoogle Scholar
  7. 7.
    McMurrich JP. The occurrence of congenital adhesions in the common iliac veins, and their relation to thrombosis of the femoral and iliac veins. Am J Med Sci. 1908;135:342–6.CrossRefGoogle Scholar
  8. 8.
    May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–27.CrossRefPubMedGoogle Scholar
  9. 9.
    Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg. 1965;52:816–21.CrossRefPubMedGoogle Scholar
  10. 10.
    Allan JC. Volume changes in the lower limb in response to postural alterations and muscular exercise. S Afr J Surg. 1964;2:75–90.Google Scholar
  11. 11.
    Lattimer CR, Mendoza E. Reappraisal of the utility of the tilt-table in the investigation of venous disease. Eur J Vasc Endovasc Surg. 2016;52(6):854–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Lattimer CR, Mendoza E, Kalodiki E. The current status of air-plethysmography in evaluating non-thrombotic iliac vein lesions. Phlebology. 2017.; doi: 10.1177/0268355516687866. [Epub ahead of print]. PMID: 28056700Google Scholar
  13. 13.
    Kundu S, Lurie F, Millward SF, et al. Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: Joint Statement of the American Venous Forum and the Society of Interventional Radiology. J Vasc Surg. 2007;46:582–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Smith JJ, Garratt AM, Guest M, Greenhalgh RM, Davies AH. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg. 1999;30:710–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Watkins MR. Deactivation of sodium tetradecyl sulphate injection by blood proteins. Eur J Vasc Endovasc Surg. 2011;41(4):521–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Breu FX, Guggenbichler S, Wollmann JC. Second European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(71):1–29.PubMedGoogle Scholar
  17. 17.
    Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy, April, 4–6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30(5):709–17.CrossRefPubMedGoogle Scholar
  18. 18.
    Gillet JL, Guedes JM, Guex JJ, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology. 2009;24:131–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Morrison N, Cavezza A, Bergan J, Partsch H. Regarding ‘stroke after varicose vein foam injection sclerotherapy’. J Vasc Surg. 2006;44:224–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27:58–60.PubMedGoogle Scholar
  21. 21.
    Parsi K. Catheter-directed sclerotherapy. Phlebology. 2009;24:98–107.CrossRefPubMedGoogle Scholar
  22. 22.
    Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg. 2008;47:830–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2009;37(3):343–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Parsi K, Exner T, Connor DE, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg. 2007;34:731–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Scurr JH, Coleridge-Smith P, Cutting P. Varicose veins: optimum compression following sclerotherapy. Ann Royal Coll Surg Eng. 1985;67:109–11.Google Scholar
  26. 26.
    Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31(6):1307–12.CrossRefPubMedGoogle Scholar
  28. 28.
    Van Bellen B, Gross WS, Verta MJ Jr, Yao JS, Bergan J. Lymphatic disruption in varicose vein surgery. Surgery. 1977;82(2):257–9.PubMedGoogle Scholar
  29. 29.
    Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94:925–36.CrossRefPubMedGoogle Scholar
  30. 30.
    Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.CrossRefPubMedGoogle Scholar
  31. 31.
    Hansen K, Morrison N, Neuhardt DL, Salles-Cunha SX. Transthoracic echocardiogram and transcranial Doppler detection of emboli after foam sclerotherapy of leg veins. J Vasc Ultrasound. 2007;31(4):213–6.CrossRefGoogle Scholar
  32. 32.
    Kalodiki E, Azzam M, Geroulakos G, Lattimer CR. Hemodynamic outcomes at 5 years from a randomized controlled trial comparing laser ablation with foam sclerotherapy. J Vasc Surg Venous Lymphat Disord. 2017;5(1):161.e6.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Christopher Richard Lattimer
    • 1
    • 2
  • Mustapha Azzam
    • 1
    • 2
  1. 1.Josef Pflug Vascular LaboratoryEaling Hospital NHS TrustMiddlesexUK
  2. 2.Imperial College, West London Vascular and Interventional CentreLondonUK

Personalised recommendations